- Zenabis Global Inc. announces that, after careful consideration and in accordance with applicable corporate and securities laws and stock exchange rules, it has decided to hold its annual meeting of shareholders at a date in the second half of 2020.
- The Company is considering an appropriate time and format for its annual meeting of shareholders and will provide further information on its annual meeting of shareholders as soon as it is available.
- The Company is also relying on the exemption provided in BC Instrument 51-516 – Temporary Exemptions from Certain Requirements to File or Send Securityholder Materials (and similar exemptions provided by the other Canadian securities regulators) to postpone the filing of its executive compensation disclosure required under Section 9.3.1(2.2) of National Instrument 51-102 – Continuous Disclosure Obligations until such time as it is filed and delivered to shareholders as part of the Company’s information circular relating to its 2020 annual meeting of shareholders.
Zenabis stock data and financials
About Zenabis Global Inc.
Zenabis is a significant Canadian licensed cultivator of medical and recreational cannabis, and a propagator and cultivator of floral and vegetable products. Zenabis employs staff coast-to-coast, across facilities in Atholville, New Brunswick ; Delta , Aldergrove , Pitt Meadows and Langley, British Columbia ; and Stellarton, Nova Scotia . Zenabis currently has 111,200 kg of licensed cannabis cultivation space across four licensed facilities. Zenabis has 3.5 million square feet of total facility space dedicated to a mix of cannabis production and cultivation and its propagation and floral business.
Zenabis expects its Zenabis Atholville, Zenabis Stellarton and Zenabis Langley facilities to be in steady state production in 2020. The Zenabis brand name is used in the medical cannabis market, the Namaste, Blazery, and Re-Up brand names are used in the adult-use recreational cannabis market, and the Tru Büch brand name is used for Zenabis’ kombucha products.
All posts made on this website are provided for information purposes only. None of the information here is intended as investment advice, as an offer or solicitation of an offer to buy or sell, or as a recommendation, endorsement, or sponsorship of any security, Company, or fund. Before making an investment decision, you should seek the advice of a qualified and registered securities professional. Candlr is not receiving payment or commissions from companies for shared content on Candlr website unless its specified. View full disclaimer HERE.